ARAF and colorectal carcinoma: Pks+ E. coli promotes a distinctive mutational signature which has been detected in a subset of CRC patients, suggesting a direct causal role of pks+ E. coli in colorectal tumorigenesis (Pleguezuelos-Manzano et al, 2020).